Qing-Jin Yi-Qi granule in the intervention of patients in rehabilitation phase of COVID-19

Tianjin University of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1) Patients who met the diagnostic criteria of covid-19 and discharged after treatment;
•2) Aged 18-75 years;
•3) Having one or more clinical manifestations of respiratory symptoms or fatigue;
•4) Patient informed consent.

•1) Patients who have undergone operations that affect lung function, such as lung transplantation, lung resection, lung volume reduction, etc;
•2) Combined with chronic lung diseases that affect lung function, such as severe chronic obstructive pulmonary disease;
•3) Patients complicated with diseases affecting cardiac function, such as pulmonary hypertension and heart failure;
•4) Accompanied by severe underlying diseases, malignant tumor, severe malnutrition, etc;
•5) Resting heart rate > 120/min;
•6) Systolic blood pressure > 180mmhg or diastolic blood pressure > 100mmhg;
•7) Severe obesity (BMI > 30kg/m2);
•8) Allergic constitution, allergic to the drug components involved in the treatment program;
•9) Patients who were judged by the investigator to be unable to comply with the study protocol;
•10) Pregnant or lactating women.

发起方

Tianjin University of TCM